Cardioprotection of Asperosaponin X on experimental myocardial ischemia injury

International Journal of Cardiology

Volumn 155, Issue 3, 2012, Pages 430-436

  Jiang, Wang Lin ^a,b   Zhang, Shu Ping ^a   Zhu, Hai Bo ^b   Hou, Jian ^b  

^a BINZHOU MEDICAL UNIVERSITY   (China)

^b Luye Pharma Group Ltd   (China)

Author keywords

Asperosaponin X; High mobility group box 1 protein; Inflammatory response; Myocardial ischemia and reperfusion; Nuclear factor kappaB

Indexed keywords

ANTIINFLAMMATORY AGENT; ASPEROSAPONIN X; GLYCYRRHIZIC ACID; HIGH MOBILITY GROUP B1 PROTEIN; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPRIFOLIACEAE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DIPSACUS ASPER; DISEASE SEVERITY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; HEART HEMODYNAMICS; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PHARMACOLOGICAL BLOCKING; PLANT ROOT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REPERFUSION INJURY; RISK REDUCTION; TREATMENT DURATION;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; DIPSACACEAE; DISEASE MODELS, ANIMAL; HMGB1 PROTEIN; I-KAPPA B PROTEINS; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NF-KAPPA B; PLANT PREPARATIONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84857781927     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2011.06.010     Document Type: Article

References (32)

1. M.L. Entman, L.H. Michael, and R.D. Rossen Inflammation in the course of early myocardial ischemia FASEB J 5 1991 2529 2537 (Pubitemid 21905802)
2. S. Frantz, J. Tillmanns, and P.J. Kuhlencordt Tissue-specific effects of the NF-κB subunit p50 on myocardial ischemia-reperfusion injury Am J Pathol 171 2007 507 512 (Pubitemid 47344683)
3. A. Kis, D.M. Yellon, and G.F. Baxter Role of nuclear factor-kappaB activation in acute ischemia-reperfusion injury in myocardium Br J Pharmacol 138 2003 894 900 (Pubitemid 36390646)
4. J.W. Kim, Y.C. Jin, and Y.M. Kim Daidzein administration in vivo reduces myocardial injury in a rat ischemia/reperfusion model by inhibiting NF-κB activation Life Sci 84 2009 227 234
5. M.T. Lotze, and K.J. Tracey High-mobility group box 1protein (HMGB1): nuclear weapon in the immune arsenal Nat Rev Immunol 5 2005 331 342 (Pubitemid 40516158)
6. H. Yang, H. Wang, and C.J. Czura The cytokine activity of HMGB1 J Leukoc Biol 78 2005 1 8 (Pubitemid 40979937)
7. H.J. Huttunen, and H. Rauvala Amphoterin as an extracellular regulator of cell motility: from discovery to disease J Intern Med 255 2004 351 366 (Pubitemid 38315276)
8. J.S. Park, F. Gamboni-Robertson, and Q. He High-mobility group box 1 protein interacts with multiple toll-like receptors Am J Physiol Cell Physiol 290 2006 C917 C924
9. R. Małek, K.K. Borowicz, and M. Jargiełło Role of NF-κB in the central nervous system Pharmacol Rep 59 2007 25 33 (Pubitemid 46522699)
10. X. Hu, C. Xu, and X. Zhou Sodium butyrate protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats Biomed Pharmacother Sep 25 2010 [Epub ahead of print]
11. T.M. Hung, M.K. Na, and P.T. Thuong Antioxidant activity of caffeoyl quinic acid derivatives from the roots of Dipsacus asper Wall J Ethnopharmacol 108 2006 188 192 (Pubitemid 44635023)
12. T. Namba The encyclopedia of wakan-yaku (traditional Sino-Japanese medicines) with color pictures I 1993 Hoikusha Publishing Company Osaka 185 186
13. N. Zhang, F. Pei, and H. Wei Isorhamnetin protects rat ventricular myocytes from ischemia and reperfusion injury Exp Toxicol Pathol 63 2011 33 38
14. Y.C. Jin, C.W. Kim, and Y.M. Kim Cryptotanshinone, a lipophilic compound of Salvia miltiorrriza root, inhibits TNF-alpha-induced expression of adhesion molecules in HUVEC and attenuates rat myocardial ischemia/reperfusion injury in vivo Eur J Pharmacol 614 2009 91 97
15. J. Zhu, Y. Qiu, and Q. Wang Low dose cyclophosphamide rescues myocardial function from ischemia-reperfusion in rats Eur J Cardiothorac Surg 34 2008 661 666
16. H. Takano, S. Manchikalapudi, and X.L. Tang Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits Circulation 98 1998 441 449 (Pubitemid 28357947)
17. M.C. Fishbein, D. Maclean, and P.R. Maroko Experimental myocardial infarction in the rat: qualitative and quantitative changes during pathologic evolution Am J Pathol 90 1978 57 70 (Pubitemid 8257477)
18. X. Wang, N. Takahashi, and H. Uramoto Chloride channel inhibition prevents ROS-dependent apoptosis induced by ischemia-reperfusion in mouse cardiomyocytes Cell Physiol Biochem 16 2005 147 154 (Pubitemid 41643015)
19. A.H. Wu, and P.L. Lane Metaanalysis in clinical chemistry: validation of cardiac troponin T as a marker for ischemic heart diseases Clin Chem 41 1995 1228 1233
20. J. Mair, E. Artner-Dworzak, and P. Lechleitner Cardiac troponin T in diagnosis of acute myocardial infarction Clin Chem 37 1991 845 852 (Pubitemid 21925927)
21. W.L. Jiang, F.H. Fu, and B.M. Xu Cardioprotection with forsythoside B in rat myocardial ischemia-reperfusion injury: relation to inflammatory response Phytomedicine 17 2010 635 639
22. K.G. Waddick, and F.M. Uckun Innovative treatment programs against cancer: II Nuclear factor-kappa B as a molecular target Biochem Pharmacol 57 1999 9 17 (Pubitemid 29012491)
23. S. Kawano, T. Kubota, and Y. Monden Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction Am J Physiol Heart Circ Physiol 291 2006 H1337 H1338
24. T. Kohno, T. Anzai, and K. Naito Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodeling Cardiovasc Res 81 2009 565 573
25. M. Andrassy, H.C. Volz, and J.C. Igwe High-mobility group box-1 in ischemia-reperfusion injury of the heart Circulation 117 2008 3216 3226
26. N. Loukili, N. Rosenblatt-Velin, and J. Li Peroxynitrite induces HMGB1 release by cardiac cells in vitro and HMGB1 upregulation in the infarcted myocardium in vivo Cardiovasc Res 89 2011 586 594
27. X. Hu, X. Zhou, and B. He Minocycline protects against myocardial ischemia and reperfusion injury by inhibiting high mobility group box 1 protein in rats Eur J Pharmacol 638 2010 84 89
28. C. Fiuza, M. Bustin, and S. Talwar Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells Blood 101 2003 2652 2660 (Pubitemid 36857626)
29. Z.G. Luan, H. Zhang, and P.T. Yang HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-α in human umbilical vein endothelial cells Immunobiology 215 2010 956 962
30. J. Yang, C. Huang, and J. Yang Statins attenuate high mobility group box-1 protein induced vascular endothelial activation: a key role for TLR4/NF-κB signaling pathway Mol Cell Biochem 345 2010 189 195
31. M. Penzo, R. Molteni, and T. Suda Inhibitor of NF-kappa B kinases alpha and beta are both essential for high mobility group box 1-mediated chemotaxis J Immunol 184 2010 4497 4509
32. L.G. Shewan, and A.J. Coats Ethics in the authorship and publishing of scientific articles Int J Cardiol 144 2010 1 2